HomeALDX • NASDAQ
add
Aldeyra Therapeutics Inc
Previous close
$5.11
Day range
$4.88 - $5.05
Year range
$2.71 - $6.55
Market cap
294.18M USD
Avg Volume
421.85K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.14M | 68.97% |
Net income | -15.11M | -84.60% |
Net profit margin | — | — |
Earnings per share | -0.25 | -78.57% |
EBITDA | -16.07M | -69.47% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 72.74M | -49.25% |
Total assets | 117.32M | -20.34% |
Total liabilities | 32.22M | 32.75% |
Total equity | 85.10M | — |
Shares outstanding | 59.55M | — |
Price to book | 3.57 | — |
Return on assets | -33.16% | — |
Return on capital | -37.59% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -15.11M | -84.60% |
Cash from operations | -7.97M | 0.62% |
Cash from investing | 5.26M | — |
Cash from financing | -197.39K | 37.49% |
Net change in cash | -2.91M | 65.11% |
Free cash flow | -1.24M | 82.28% |
About
Founded
2004
Headquarters
Website
Employees
9
